Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 1
2021 2
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Thoracic NUT Carcinoma"
Page 1
NUT carcinoma of the lung.
Lantuejoul S, Pissaloux D, Ferretti GR, McLeer A. Lantuejoul S, et al. Semin Diagn Pathol. 2021 Sep;38(5):72-82. doi: 10.1053/j.semdp.2021.06.005. Epub 2021 Jun 16. Semin Diagn Pathol. 2021. PMID: 34176698 Review.
NUT carcinoma of the thorax is a rare and very aggressive tumor, whose definition is based on the demonstration of a nuclear protein in testis (NUTM1; also known as NUT) gene fusion on 15q14 with different partners from the bromodomain-containing prote
NUT carcinoma of the thorax is a rare and very aggressive tumor, whose definition is based on the demonstration of a nu
NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies.
Yoshida A. Yoshida A. Histopathology. 2024 Jan;84(1):86-101. doi: 10.1111/his.15063. Epub 2023 Oct 24. Histopathology. 2024. PMID: 37873676 Review.
NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour are unique entities in the 5th edition of the World Health Organisation (WHO) Classification of Thoracic Tumours, whose definitions include molecular genetic abnormalities. ...Phenoty
NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour are unique entities in the 5th edition of the Worl
Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.
Xie XH, Wang LQ, Qin YY, Lin XQ, Xie ZH, Liu M, Zhang JX, Ouyang M, Liu J, Gu YY, Li SY, Zhou CZ. Xie XH, et al. Orphanet J Rare Dis. 2020 Jul 10;15(1):183. doi: 10.1186/s13023-020-01449-x. Orphanet J Rare Dis. 2020. PMID: 32650830 Free PMC article.
OBJECTIVE: NUT midline carcinoma (NMC), a rare type of squamous cell carcinoma, is genetically characterised by NUT midline carcinoma family member 1 (NUTM1) gene rearrangement. ...A wide range of TMB (1.75-73.81 mutations/Mbp) was observed
OBJECTIVE: NUT midline carcinoma (NMC), a rare type of squamous cell carcinoma, is genetically characterised by NUT
Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study.
Jung M, Kim S, Lee JK, Yoon SO, Park HS, Hong SW, Park WS, Kim JE, Kim J, Keam B, Kim HJ, Kang HJ, Kim DW, Jung KC, Kim YT, Heo DS, Kim TM, Jeon YK. Jung M, et al. Oncologist. 2019 Aug;24(8):e740-e748. doi: 10.1634/theoncologist.2018-0477. Epub 2019 Jan 29. Oncologist. 2019. PMID: 30696721 Free PMC article.
Here, we report on the clinicopathological characteristics of Korean patients with NUT carcinoma and the in vitro efficacy of MYC-targeting agents against patient-derived NUT carcinoma cell lines. ...IMPLICATIONS FOR PRACTICE: NUT carcinoma
Here, we report on the clinicopathological characteristics of Korean patients with NUT carcinoma and the in vitro efficacy of …
NUT carcinoma in children and adults: A multicenter retrospective study.
Lemelle L, Pierron G, Fréneaux P, Huybrechts S, Spiegel A, Plantaz D, Julieron M, Dumoucel S, Italiano A, Millot F, Le Tourneau C, Leverger G, Chastagner P, Carton M, Orbach D. Lemelle L, et al. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26693. Epub 2017 Jun 23. Pediatr Blood Cancer. 2017. PMID: 28643357
BACKGROUND: Nuclear protein of the testis (NUT) carcinoma (formerly NUT midline carcinoma) is an aggressive tumor defined by the presence of NUT rearrangement with a poor prognosis. ...METHODS: This retrospective multicenter study was based on r …
BACKGROUND: Nuclear protein of the testis (NUT) carcinoma (formerly NUT midline carcinoma) is an aggressive tumo …
Diagnostic and Predictive Immunohistochemistry for Non-Small Cell Lung Carcinomas.
Hung YP, Sholl LM. Hung YP, et al. Adv Anat Pathol. 2018 Nov;25(6):374-386. doi: 10.1097/PAP.0000000000000206. Adv Anat Pathol. 2018. PMID: 30188361 Review.
In this review, we discuss diagnostic and predictive immunohistochemical markers in NSCLC, one of the most common tumors encountered in surgical pathology. We highlight 2 emerging diagnostic markers: nuclear protein in testis (NUT) for NUT carcinoma; S …
In this review, we discuss diagnostic and predictive immunohistochemical markers in NSCLC, one of the most common tumors encountered …
Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
Agaimy A, Haller F, Renner A, Niedermeyer J, Hartmann A, French CA. Agaimy A, et al. Am J Surg Pathol. 2022 Feb 1;46(2):281-288. doi: 10.1097/PAS.0000000000001774. Am J Surg Pathol. 2022. PMID: 34232599 Free PMC article.
NUT carcinoma (aka NUT midline carcinoma) is a rare, still significantly underrecognized aggressive malignancy. Although historically considered a midline malignancy of children and young adults, NUT carcinoma can originate in almost any
NUT carcinoma (aka NUT midline carcinoma) is a rare, still significantly underrecognized aggressive malignancy.
NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
Jung M, Kim SI, Kim JW, Jeon YK, Lee C. Jung M, et al. Int J Gynecol Pathol. 2022 May 1;41(3):292-297. doi: 10.1097/PGP.0000000000000801. Epub 2021 Jun 23. Int J Gynecol Pathol. 2022. PMID: 34166280
NUT carcinoma is an aggressive epithelial malignancy defined by NUTM1 translocation, usually arising in the head/neck or thorax regions and showing squamous differentiation. ...After 2 cycles of chemotherapy, bilateral pleural effusion developed that were dia
NUT carcinoma is an aggressive epithelial malignancy defined by NUTM1 translocation, usually arising in the head/neck or th
Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Ninomiya H, Sato Y, Inamura K, Dobashi A, Takeuchi K, Mitani H, Mun M, Nishio M, Ishikawa Y. Ninomiya H, et al. Diagn Pathol. 2024 Feb 7;19(1):27. doi: 10.1186/s13000-024-01448-7. Diagn Pathol. 2024. PMID: 38326851 Free PMC article.
INTRODUCTION: NUT carcinoma is a rare cancer associated with a poor prognosis. ...METHODS: Eight cases of NUT carcinoma were examined along with eight basaloid squamous cell carcinomas and thirteen cases of small cell carcinoma using an i …
INTRODUCTION: NUT carcinoma is a rare cancer associated with a poor prognosis. ...METHODS: Eight cases of NUT carcin
Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW, Hsieh TH, Chu PY, Hsieh SM, Liu ML, Lee JC, Liu YR, Ku JW, Kao YC. Chien YW, et al. Genes Chromosomes Cancer. 2019 Nov;58(11):809-814. doi: 10.1002/gcc.22785. Epub 2019 Jul 30. Genes Chromosomes Cancer. 2019. PMID: 31334571
NUTM1 gene rearrangement is the genetic hallmark of NUT carcinoma, an aggressive tumor that most commonly affects the thoracic and head and neck regions and often exhibits squamous differentiation. ...MYC mRNA up-regulation and immunoreactivity, a common find …
NUTM1 gene rearrangement is the genetic hallmark of NUT carcinoma, an aggressive tumor that most commonly affects the thora